Alex Spira, MD, PhD on CX-2029 Targeting CD71 #ASCO2020 @VCSpecialists

Alex Spira, MD, PhD on CX-2029 Targeting CD71 #ASCO2020 @VCSpecialists

User Photo
Cancer-News

2 weeks
10 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Alex Spira, MD, PhD of Virginia Cancer Specialists @VCSpecialists discusses CX-2029, a PROBODY drug conjugate targeting CD71: Results from a first-in-human study in patients with advanced cancer presented at this year's virtual ASCO.

Read here: https://meetinglibrary.asco.org/record/185085/abstract

Up Next Autoplay
User Photo